We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Further Analysis of Vacc-4x Phase IIb Study Shows a Statistically Significant Reduction in Viral Load Over Placebo

News   Nov 26, 2010

 
Further Analysis of Vacc-4x Phase IIb Study Shows a Statistically Significant Reduction in Viral Load Over Placebo
 
 
Advertisement
 

RELATED ARTICLES

Swapping Alpha Cells for Beta Cells To Treat Diabetes

News

Blocking cell receptors for glucagon, the counter-hormone to insulin, cured mouse models of diabetes by converting glucagon-producing cells into insulin producers instead.

READ MORE

Making Personalized Cancer Therapies Effective for Multiple Patients

News

A new commentary in Science proposes that an emerging method of protein-based immunotherapy that works by targeting commonly occurring mutations in cancer cells, could lead to treatments that are effective for oncology patients.

READ MORE

Asymptomatic COVID-19 Associated With a Balanced T-Cell Response

News

Researchers attempting to determine whether or not an infected individual will develop COVID-19 suggest that clearing the virus without developing symptoms requires T cells to mount an efficient immune response that produces a careful balance of pro- and anti-inflammatory molecules.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE